Minnesota Drugmaker Cited for Cleaning Deficiencies
The FDA hit Minnesota generic drug manufacturer Upsher Smith Laboratories with a Form 483 over cleaning and batch production violations at its Plymouth facility.
Source: Drug Industry Daily
The FDA hit Minnesota generic drug manufacturer Upsher Smith Laboratories with a Form 483 over cleaning and batch production violations at its Plymouth facility.
Source: Drug Industry Daily